Bank of America’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,045
Closed -$355 6038
2025
Q4
$355 Sell
1,045
-2,500
-71% -$843 ﹤0.01% 6615
2025
Q3
$1.22K Buy
3,545
+2,500
+239% +$710 ﹤0.01% 7464
2025
Q2
$230 Hold
1,045
﹤0.01% 7816
2025
Q1
$248 Buy
1,045
+1,000
+2,222% +$298 ﹤0.01% 7646
2024
Q4
$9 Hold
45
﹤0.01% 8095
2024
Q3
$9 Buy
+45
New +$9 ﹤0.01% 8052

Other funds holding DRTSW

Bank of America's DRTSW Position: Q1 2026 in Review

Bank of America sold out of Alpha Tau Medical Warrant (DRTSW) in Q1 2026, closing a stake of 1,045 shares — an estimated $355 sold.

Bank of America first reported a position in DRTSW in Q3 2024 and held it in 6 quarters. The position peaked at $1.22K in Q3 2025. 21 funds tracked by Wall St. Rank hold DRTSW as of Q1 2026.

  • Bank of America reported no remaining Alpha Tau Medical Warrant position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 1,045 Alpha Tau Medical Warrant shares in Q1 2026, an estimated $355.
  • Bank of America first reported a position in Alpha Tau Medical Warrant in Q3 2024 and held it in 6 quarters.
  • Bank of America's Alpha Tau Medical Warrant position peaked at $1.22K in Q3 2025.
  • 21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.